SCHEMBL7612979

SCHEMBL7612979

Nc1nc(O)c(O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15907848 0.63 PNP (0.41)
SCHEMBL7672758 0.61 PNP (0.48)
SCHEMBL5158035 0.59
SCHEMBL3180710 0.58 CDK1 (0.52)
SCHEMBL5174334 0.56
SCHEMBL215067 0.53
SCHEMBL4466079 0.53
SCHEMBL3956367 0.53
SCHEMBL5157876 0.53
SCHEMBL9386099 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380165-B1 THAT IS ANTIGENIC AND USEFUL FOR FORMING ANTIBODIES HAVING UTILITY IN STANDARDIZING DIAGNOSTIC ASSAYS, COMPRISING A LYSINE COMPONENT, AN ARGININE COMPONENT AND A REDUCING SUGAR COMPONENT THE PICOWER INSTITUTE FOR MEDICAL RESEARCH 2002-04-30 US disclosed
US-20020022234-A1 IMMUNOLOGICAL ADVANCED GLYCATION ENDPRODUCT CROSSLINK PICOWER INSTITUTE FOR MEDICAL RESEARCH 2002-02-21 US disclosed
EP-1018005-A1 METHODS FOR MEASURING AND ELIMINATING ADVANCED GLYCATION ENDPRODUCTS THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 2000-07-12 EP disclosed
WO-1999014587-A1 METHODS FOR MEASURING AND ELIMINATING ADVANCED GLYCATION ENDPRODUCTS THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1999-03-25 WO disclosed